These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9853211)

  • 1. MRI of bone metastases.
    Vanel D; Bittoun J; Tardivon A
    Eur Radiol; 1998; 8(8):1345-51. PubMed ID: 9853211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of bone metastases and choice of sequence: spin echo, in-phase gradient echo, diffusion, and contrast medium.
    Vanel D; Casadei R; Alberghini M; Razgallah M; Busacca M; Albisinni U
    Semin Musculoskelet Radiol; 2009 Jun; 13(2):97-103. PubMed ID: 19455472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI of bone marrow disorders.
    Vanel D; Dromain C; Tardivon A
    Eur Radiol; 2000; 10(2):224-9. PubMed ID: 10663751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[Advantages and limitations of whole-body bone marrow MRI using Turbo-STIR sequences in comparison to planar bone scans] ].
    Tausig A; Manthey N; Berger F; Sommer H; Pfluger T; Hahn K
    Nuklearmedizin; 2000 Sep; 39(6):174-9. PubMed ID: 11057409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI of bone tumors: Fast STIR imaging as a substitute for T1-weighted contrast-enhanced fat-suppressed spin-echo imaging.
    Tokuda O; Hayashi N; Matsunaga N
    J Magn Reson Imaging; 2004 Apr; 19(4):475-81. PubMed ID: 15065172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic imaging of bone marrow composition in vertebral bodies.
    Weis J; Ciray I; Ericsson A; Lindman H; Aström G; Ahlström H; Hemmingsson A
    MAGMA; 2001 Aug; 13(1):15-8. PubMed ID: 11410392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images.
    Mirowitz SA; Apicella P; Reinus WR; Hammerman AM
    AJR Am J Roentgenol; 1994 Jan; 162(1):215-21. PubMed ID: 8273669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR Diagnosis of Bone Metastases at 1.5 T and 3 T: Can STIR Imaging Be Omitted?
    Ohlmann-Knafo S; Tarnoki AD; Tarnoki DL; Pickuth D
    Rofo; 2015 Oct; 187(10):924-32. PubMed ID: 26085176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer?
    Perrin-Resche I; Bizais Y; Buhe T; Fiche M
    Eur J Nucl Med; 1993 May; 20(5):420-5. PubMed ID: 8390936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 1H relaxation times of water in human bone marrow by fat-suppressed turbo spin echo in comparison to MR spectroscopic methods.
    Träber F; Block W; Layer G; Bräucker G; Gieseke J; Kretzer S; Hasan I; Schild HH
    J Magn Reson Imaging; 1996; 6(3):541-8. PubMed ID: 8724421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnetic resonance imaging in screening for bone metastasis? A prospective comparison with bone scintigraphy].
    Theissen P; Smolarz K; Scharl A; Groth A; Scheidhauer K; Voth E; Schicha H
    Nuklearmedizin; 1994 Aug; 33(4):132-7. PubMed ID: 7971287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of bone metastasis with whole body MRI?].
    Grüning T; Tiepolt C; Kropp J; Franke WG
    Radiologe; 2001 Sep; 41(9):792-5. PubMed ID: 11593804
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow abnormalities of foot and ankle: STIR versus T1-weighted contrast-enhanced fat-suppressed spin-echo MR imaging.
    Schmid MR; Hodler J; Vienne P; Binkert CA; Zanetti M
    Radiology; 2002 Aug; 224(2):463-9. PubMed ID: 12147843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetization transfer contrast MRI of musculoskeletal neoplasms.
    Li KC; Hopkins KL; Moore SG; Loh NN; Bergman G; Pike GB; Glover GH
    Skeletal Radiol; 1995 Jan; 24(1):21-5. PubMed ID: 7709247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow imaging using STIR at 0.5 and 1.5 T.
    Jones KM; Unger EC; Granstrom P; Seeger JF; Carmody RF; Yoshino M
    Magn Reson Imaging; 1992; 10(2):169-76. PubMed ID: 1564986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superparamagnetic iron oxide (SPIO) MRI contrast agent for bone marrow imaging: differentiating bone metastasis and osteomyelitis.
    Fukuda Y; Ando K; Ishikura R; Kotoura N; Tsuda N; Kato N; Yoshiya S; Nakao N
    Magn Reson Med Sci; 2006 Dec; 5(4):191-6. PubMed ID: 17332709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance imaging for bone marrow metastases of neuroblastoma].
    Couanet D; Geoffray A
    Bull Cancer; 1988; 75(1):91-6. PubMed ID: 3359059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The nuclear magnetic tomographic diagnosis of focal lesions of the red bone marrow. The optimization of the acquisition parameters for GE and SE sequences].
    Seiderer M; Wagner H; Stäbler A; Fink U
    Rofo; 1994 May; 160(5):453-8. PubMed ID: 8173055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.